EXPERIENCE WITH INTRAOPERATIVE CHEMOIMMUNOTHERAPY AFTER RADICAL OPERATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
https://doi.org/10.24060/2076-3093-2012-0-1-10-14
Abstract
The purpose of this study was to evaluate the tolerability and effects on the immune status of patients with radically resection of non-small cell lung cancer new method of intraoperative chemoimmunotherapy. Pilot results treatment of twenty patients indicate a satisfactory tolerability and positive impact on the immune status. Further study of the effectiveness of this method as a component of the complex treatment of early-stage nonsmall cell lung cancer seems to be promising.
About the Authors
P. A. Anistratov
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
Yu. N. Lazutin
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
S. A. Zinkovich
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
E. Yu. Zlatnik
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
G. Z. Sergostyantz
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
G. I. Zakora
Rostov Research Institute of Oncology
Russian Federation
Russian Federation
References
1. Давыдов М.И., Полоцкий Б.Е., Аллахвердиев А.К. Систематическая медиастинальная лимфатическая диссекция стандарт в хирургическом лечении больных немелкоклеточным раком легкого 1, 2 и 3А стадии // Пульмонология. 2007. №3.С. 72-76.
2. Трахтенберг А.Х., Чиссов В.И. Рак легкого. М.: «ГЕОТАР-Медиа», 2009. С. 339-345.
3. Amasura Y., Goya T., Koshiishi Y., Sohara Y., Eguchi K., Mori M., Nakanishi Y., Tsuchiya R., Shimokata K., Inoue H., Nukiwa T. and Miyaoka E.A Japanese Lung Cancer Registry study: Prognosis of 13.010 resected Lung Cancers // J. Thorac. Oncol. 2008. Vol. 3. P. 46-52.
4. Fang D., Zhang D., Huang G., Zhang R., Wang L and Zhang D. Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1.905 cases // Ann. Thorac. Surg. 2001. Vol. 72. P. 1155-1159.
5. Goya T., Amasura Y., Yoshimura H., Kato H., Shimokata K., Tsuchiya R., Sohara Y., Miya T and Miyaoka E. Prognosis of 6.644 resected non-small lung cancers in Japan: Japanese Lung Cancer Registry study // Lung Cancer. 2005. – Vol. 50. – P. 227-234.
6. Konrad M.W., Hemstreet G., Hersh E.M., et all. / Pharmacokinetics of recombinant interleukin-2 in humans // Cancer Res. 1990. №50. Р. 2009-2017.
7. Mountain C.F. /Revision in the International System for Staging Lung Cancer // Chest. – 1997. Vol. 111. P. 1710-1717.
8. Nicolson M., Gilligan D., Smith I.et all. / Preoperative chemotherapy in patients with resectable non-small-cell lung cancer (NSCLC): First results of the MRC/NVALT/EORTC 08012 multi-center randomized trial // J.Clin.Oncol. 2007. Vol. 25. №18. P. 7518.
9. Pignon J.P., Tribodet H., Scagliotti G.V. et all. Lung Adjuvant Cisplatin Evaluations (LAСE):A pooled analysis of the five randomized clinical Trials including 4.584 patients // J.Clin.Oncol. – 2006. – Vol. 24. № 18. – P. 7008.
10. Van Rens M.T., de la Riviere A.B., Elbers H.R. and van Den Bosch J.M. Prognostic assessment of 2361 patients who underwent pulmonary resections for non-small cell Lung Cancer, stage 1, 2 and 3A // Chest. – 2000. – Vol. 117. P. 374-379.
Review
For citations:
Anistratov P.A., Lazutin Yu.N., Zinkovich S.A., Zlatnik E.Yu., Sergostyantz G.Z., Zakora G.I. EXPERIENCE WITH INTRAOPERATIVE CHEMOIMMUNOTHERAPY AFTER RADICAL OPERATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER. Creative surgery and oncology. 2012;(1):10-14. (In Russ.) https://doi.org/10.24060/2076-3093-2012-0-1-10-14
Views:
520
Email this article 